YAP1 and ovarian cancer: Several studies have reported that verteporfin can inhibit YAP1 transcriptional activity thereby leading to tumor growth suppression and sensitization to cytotoxic agents in a variety of tumor types, such as esophageal cancer, rhabdomyosarcoma, ovarian cancer and bladder cancer [23, 28, 43, 44].